lunes, 22 de mayo de 2023

Study shows potential benefit of sacubitril/valsartan in heart failure patients with EF over 40%

Study shows potential benefit of sacubitril/valsartan in heart failure patients with EF over 40%

No hay comentarios:

Publicar un comentario